Mark Allen O’Rourke
Mark Allen O’Rourke publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Cancer Treatment and Pharmacology, Cancer survivorship and care and Colorectal Cancer Treatments and Studies.
- World rank
- #617,688 of 7,710,434 ranked researchers
- Rank in United States
- #211,381 of 1,627,098
- Works
- 118
- Citations
- 8.3k
- Citations per work
- 69.9
What does Mark Allen O’Rourke research?
Mark Allen O’Rourke's work is mostly in Medicine (45%), Health Professions (5%), Economics, Econometrics and Finance (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5949.6%
- Medicine5344.8%
- Health Professions64.8%
- Everything else4941.8%
- Social Sciences108.6%
- 1Oncology27% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Surgery5% of their works
- 4Economics and Econometrics5% of their works
- 5General Health Professions5% of their works
- 6Education4% of their works
Research topics
Which keywords describe Mark Allen O’Rourke's research?
The keywords of their largest research topics: Quality of Life, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Chemotherapy, Cancer Survivorship, Patient-Reported Outcomes, Cetuximab and EGFR Mutations.
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Palliative Care
- Financial Toxicity
- Targeted Therapy
- EGFR Mutations
- Patient-Reported Outcomes
- Chemotherapy
- Chemotherapy-Induced Peripheral Neuropathy
- Quality of Life
- Taxanes
- Cancer Survivorship
- Cetuximab
- KRAS Mutations
- Cost of Care
- End-of-Life
- CT Screening
- Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Quality of Life352 topics
- Chemotherapy-Induced Peripheral Neuropathy191 topic
- Taxanes191 topic
- Chemotherapy182 topics
- Cancer Survivorship161 topic
- Patient-Reported Outcomes161 topic
- Cetuximab111 topic
- EGFR Mutations111 topic
- KRAS Mutations111 topic
- Targeted Therapy111 topic
- Cost of Care91 topic
- Financial Toxicity91 topic
- End-of-Life81 topic
- Palliative Care81 topic
- CT Screening71 topic
- Immune Checkpoint Blockade71 topic
- Lung Cancer71 topic
- PD-1 and PD-L171 topic
Where does Mark Allen O’Rourke work?
Mark Allen O’Rourke's main affiliation in the publication record is Prisma Health, United States.
How many publications and citations does Mark Allen O’Rourke have?
OpenAlex counts 118 works and 8,253 citations for Mark Allen O’Rourke, an h-index of 33, ranking #617,688 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Allen O’Rourke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.